Results 81 to 90 of about 934,676 (365)

Exercise Testing of Muscle Strength in Military [PDF]

open access: yesMilitary Medicine, 2019
Abstract Introduction Strength training has been routinely used in exercise programs of military groups; however, no review has been ever conducted to clarify the selection of exercise tests to monitor its effectiveness.
Nikolaidis, Pantelis T   +3 more
openaire   +2 more sources

Grip and muscle strength dynamometry in acute burn injury: Evaluation of an updated assessment protocol [PDF]

open access: yes, 2018
External stabilization is reported to improve reliability of hand held dynamometry, yet this has not been tested in burns. We aimed to assess the reliability of dynamometry using an external system of stabilization in people with moderate burn injury and
Edgar, Dale W   +4 more
core   +1 more source

Neuromuscular magnetic stimulation counteracts muscle decline in ALS patients: results of a randomized, double-blind, controlled study [PDF]

open access: yes, 2019
The aim of the study was to verify whether neuromuscular magnetic stimulation (NMMS) improves muscle function in spinal-onset amyotrophic lateral sclerosis (ALS) patients.
Cambieri, Chiara   +15 more
core   +1 more source

Nerve Excitability in Asymptomatic Carriers and Amyotrophic Lateral Sclerosis Patients With C9orf72

open access: yesAnnals of Clinical and Translational Neurology, EarlyView.
ABSTRACT Objective We investigated the effects of C9orf72 mutation carriership on peripheral nerve excitability in asymptomatic individuals from families with a history of C9orf72 amyotrophic lateral sclerosis (ALS) and patients. Methods We included 47 asymptomatic individuals from families with a history of C9orf72 ALS, of whom 23 were carriers (C9 ...
Diederik J. L. Stikvoort García   +3 more
wiley   +1 more source

The Diverse Neuromuscular Spectrum of VPS13A Disease

open access: yesAnnals of Clinical and Translational Neurology, EarlyView.
ABSTRACT Objective VPS13A disease (chorea‐acanthocytosis) is a rare neurodegenerative disorder caused by biallelic variants in VPS13A, typically presenting with hyperkinetic movement disorders, while neuromuscular signs are often mild. The aim of the project was to investigate the frequency and severity of neuromuscular impairment in VPS13A disease ...
Anne Buchberger   +16 more
wiley   +1 more source

Investigation of knee flexor and extensor muscle strength in athletes with and without trunk muscle strength asymmetry

open access: yesAdvances in Rehabilitation, 2021
Aydin Balci   +4 more
doaj   +1 more source

Associations between isokinetic muscle strength, high-level functional performance, and physiological parameters in patients with chronic obstructive pulmonary disease

open access: yesInternational Journal of COPD, 2012
Scotty J Butcher,1 Brendan J Pikaluk,2 Robyn L Chura,1 Mark J Walkner,1 Jonathan P Farthing,2 Darcy D Marciniuk31School of Physical Therapy, University of Saskatchewan, Saskatoon, SK, Canada; 2College of Kinesiology, University of Saskatchewan, Saskatoon,
Butcher SJ   +5 more
doaj  

Sarcopenia defined by the global leadership initiative in sarcopenia (GLIS) consensus predicts adverse postoperative outcomes in patients undergoing radical gastrectomy for gastric cancer: analysis from a prospective cohort study

open access: yesBMC Cancer
Background Global Leadership Initiative in Sarcopenia (GLIS) has recently established a conceptional definition of sarcopenia, which incorporated muscle strength, mass, and muscle-specific strength as three components of sarcopenia.
Gao-Feng Wu   +10 more
doaj   +1 more source

Gambaran Kekuatan Otot Pasien Stroke Non Hemoragik Setelah Diberikan Latihan Bola Karet Dan Thera Band Hand Di Rumah Sakit Rk. Charitas Palembang [PDF]

open access: yes, 2019
Background: Non-hemoragic stroke patients has upper extermity muscle weakness resulting in decreased muscle strength. Exercise done on non-hemoragic stroke patients to with simple movement and beneficial exercises to increase muscle strength. Objective:
Misno, Tatiana Furi
core  

Interleukin‐6 as a Key Biomarker in Facioscapulohumeral Dystrophy: Evidence From Longitudinal Analyses

open access: yesAnnals of Clinical and Translational Neurology, EarlyView.
ABSTRACT Objective Facioscapulohumeral muscular dystrophy type 1 (FSHD1) is a progressive neuromuscular disorder with no approved treatments. Identifying reliable biomarkers is critical to monitor disease severity, activity, and progression. Interleukin‐6 (IL‐6) has been proposed as a candidate biomarker, but longitudinal validation is limited ...
Jonathan Pini   +13 more
wiley   +1 more source

Home - About - Disclaimer - Privacy